U.S. markets closed
  • S&P 500

    4,076.57
    -3.54 (-0.09%)
     
  • Dow 30

    34,395.01
    -194.76 (-0.56%)
     
  • Nasdaq

    11,482.45
    +14.45 (+0.13%)
     
  • Russell 2000

    1,881.68
    -4.90 (-0.26%)
     
  • Crude Oil

    81.44
    +0.22 (+0.27%)
     
  • Gold

    1,803.10
    +2.00 (+0.11%)
     
  • Silver

    22.94
    +0.10 (+0.46%)
     
  • EUR/USD

    1.0532
    +0.0124 (+1.19%)
     
  • 10-Yr Bond

    3.5290
    -0.1740 (-4.70%)
     
  • GBP/USD

    1.2255
    +0.0193 (+1.60%)
     
  • USD/JPY

    135.2580
    -2.8220 (-2.04%)
     
  • BTC-USD

    16,965.98
    -204.32 (-1.19%)
     
  • CMC Crypto 200

    401.44
    -4.71 (-1.16%)
     
  • FTSE 100

    7,558.49
    -14.56 (-0.19%)
     
  • Nikkei 225

    28,226.08
    +257.09 (+0.92%)
     

‘There’s no way that patients are going to be able to afford that.’ Why aren’t new drugs that can help you lose weight more widely used?

‘There’s no way that patients are going to be able to afford that.’ Why aren’t new drugs that can help you lose weight more widely used?

In clinical trials, Novo Nordisk’s (DK:NOVO) Wegovy helped adults lose about 15% of their body weight. Eli Lilly’s (LLY) tirzepatide, meanwhile, is still in clinical trials, but data from a Phase 3 trial showed that people taking the drug lost up to 22% of their body weight. “I was prescribing Wegovy almost as fast as I could,” said Elizabeth Fryoux, a physician who practices obesity medicine at the University of Mississippi Medical Center.